Form D · Other
Farma Genetix, Inc.
Brookline, MA · CIK 0001851435
Offering snapshot reported Mar 25, 2021 · SEC filing
- Reported sold
- $450K Offering amount: $600K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 16, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2021 | Initial | $450,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-393552
Source: Form D, filed Mar 25, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sung Park | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
20 Englewood Ave. Unit 201
Brookline, MA, 02445
Brookline, MA, 02445